Shahzad Bhatti
Role not yet determined Is this you? Add your title
Also affiliated: University College Hospital (2013); King Edward Medical University (2024); University of Lahore (2010–2018); Kinnaird College for Women University (2021–2022); University of Illinois Urbana-Champaign (2016–2018); Fatima Jinnah Medical University (2022–2023); Rashid Latif Medical College (2017–2021); University of Cambridge (2010); Latifa Hospital (2021–2022); University of Health Sciences Lahore (2011–2021); University College London (2013)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Shahzad Bhatti's research focuses on several distinct areas, including the quality assurance of assisted reproductive technologies (ART) and the analysis of biological transport phenomena. He has investigated the role of artificial intelligence in ART quality assurance and explored the impact of extracellular microRNAs on in vitro fertilization outcomes. Bhatti's work also includes the study of peristaltic-ciliary transport of Jeffrey fluid in relation to in vitro preimplantation embryo development. His research portfolio extends to public health, with a systematic review on antibiotic resistance in Pakistan. Additionally, Bhatti has contributed to cardiovascular research, analyzing outcomes of percutaneous coronary interventions for acute myocardial infarction and investigating carotid artery disease in stroke patients. His scholarship includes 75 publications and 687 citations, with an h-index of 15.
Metrics
- h-index: 15
- Publications: 75
- Citations: 695
Selected Publications
-
P1.11.27 Optimal Immunotherapy Regimen for STK11 or KEAP1 Mutant Metastatic Non-Small Cell Lung Cancer (2025)
-
A RARE CASE OF DESMOPLASTIC SMALL ROUND CELL TUMOR WITH LEPTOMENINGEAL CARCINOMATOSIS (2022)
Collaboration Network
Top Collaborators
- A RARE CASE OF DESMOPLASTIC SMALL ROUND CELL TUMOR WITH LEPTOMENINGEAL CARCINOMATOSIS
- A RARE CASE OF DESMOPLASTIC SMALL ROUND CELL TUMOR WITH LEPTOMENINGEAL CARCINOMATOSIS
- P1.11.27 Optimal Immunotherapy Regimen for STK11 or KEAP1 Mutant Metastatic Non-Small Cell Lung Cancer
Similar Researchers
Based on overlapping research topics